Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.

about

Laser-induced interstitial thermotherapy via a single-needle delivery system: Optimal conditions of ablation, pathological and ultrasonic changes.

P2860

Q35724839-078DC352-471B-4E10-ACA4-0D73FD404D34

P2860

Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.

Item

http://www.wikidata.org/entity/Q35720473

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pharmacokinetic study of conve ...... rabbit VX2 liver tumor model.

@ast

Pharmacokinetic study of conve ...... rabbit VX2 liver tumor model.

@en

type

Item

label

Pharmacokinetic study of conve ...... rabbit VX2 liver tumor model.

@ast

Pharmacokinetic study of conve ...... rabbit VX2 liver tumor model.

@en

prefLabel

Pharmacokinetic study of conve ...... rabbit VX2 liver tumor model.

@ast

Pharmacokinetic study of conve ...... rabbit VX2 liver tumor model.

@en

P1476

Pharmacokinetic study of conve ...... rabbit VX2 liver tumor model.

@en

P2093

Ahmad Parvinian

http://www.w3.org/2001/XMLSchema#string

Ron C Gaba

http://www.w3.org/2001/XMLSchema#string

Zane Z Hauck

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib in advanced hepatocellular carcinoma

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Management of hepatocellular carcinoma

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Development, growth, propagation, and angiographic utilization of the rabbit VX2 model of liver cancer: a pictorial primer and "how to" guide.

Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis

Chemoembolization of hepatocellular carcinoma.

P304

235-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5152/DIR.2014.14394

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Richard van Breemen

Leigh C Casadaban

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274396776

http://www.w3.org/2001/XMLSchema#string

P698

25835078

http://www.w3.org/2001/XMLSchema#string

P932

4463267

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.

about

P2860

P2860

Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932